guide ittm sgrna screening kit (TaKaRa)
95
Structured Review
TaKaRa
guide ittm sgrna screening kit
Guide Ittm Sgrna Screening Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/guide+ittm+sgrna+screening+kit/Guide-it+sgRNA+Screening+Kit/pmc11912399__pnas__2415072122__sapp-180-4-8
Average 95 stars, based on 63 article reviews
Guide Ittm Sgrna Screening Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/guide+ittm+sgrna+screening+kit/Guide-it+sgRNA+Screening+Kit/pmc11912399__pnas__2415072122__sapp-180-4-8
Average 95 stars, based on 63 article reviews
guide ittm sgrna screening kit - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Sequencing:Article Title: Abstract Article Snippet: FRIDAY, OC TOBER 11, 2019 OR AL ABSTR AC TS SESSION 20 0 ON PERV 200.1 | Characterization of PERV virus particles in the CRISPR/Cas9 inactivated cell line PK15 clone 15 Antonia W. Godehardt 1 ; Nicole Fischer 1 ; Paula Rauch 1 ; Barbara Gulich 1 ; Klaus Boller 1 ; George M. Church 2 ; Ralf Toenjes 1 1 Division of Medical Biotechnology, PaulEhrlichInstitut, Langen, Germany ; 2 Department of Genetics, Harvard Medical School, Boston, MA, United States Introduction : PERV infecting human cells in vitro is a major objection for conducting XTx clinical trials.. CRISPR/Cas9 technology enabled for the first time the generation of living pigs, free of functional PERV (1, 2).. However, the susceptibility of these animals and medicinal products derived thereof towards reinfection with PERV remains unclear. In Vitro:Article Title: Abstract Article Snippet: FRIDAY, OC TOBER 11, 2019 OR AL ABSTR AC TS SESSION 20 0 ON PERV 200.1 | Characterization of PERV virus particles in the CRISPR/Cas9 inactivated cell line PK15 clone 15 Antonia W. Godehardt 1 ; Nicole Fischer 1 ; Paula Rauch 1 ; Barbara Gulich 1 ; Klaus Boller 1 ; George M. Church 2 ; Ralf Toenjes 1 1 Division of Medical Biotechnology, PaulEhrlichInstitut, Langen, Germany ; 2 Department of Genetics, Harvard Medical School, Boston, MA, United States Introduction : PERV infecting human cells in vitro is a major objection for conducting XTx clinical trials.. CRISPR/Cas9 technology enabled for the first time the generation of living pigs, free of functional PERV (1, 2).. However, the susceptibility of these animals and medicinal products derived thereof towards reinfection with PERV remains unclear. |